CINXE.COM
Alkermes – A Global Biopharmaceutical Company
<!DOCTYPE html> <html lang="en"> <head id="head"> <meta name="viewport" content="width=device-width, initial-scale=1" /> <meta charset="UTF-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <title>Alkermes – A Global Biopharmaceutical Company</title> <meta name="ahrefs-site-verification" content="40e2b2f5f4748097d8ed32caa1cff9681ccd528add9f8ed281f639d4a3c76701"> <meta name="google-site-verification" content="NC2BeZykS3AUGbf2NjWQChMDT1y3qtELhLX4ebDtJpg" /> <meta name="description" content="Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience. "> <meta name="keywords" content=" Neuroscience, LYBALVI (olanzapine and samidorphan), Schizophrenia, Bipolar I Disorder, Neurology, alcohol dependence, opioid dependence, narcolepsy, sleep disorder, ALKS 2680"> <meta name="msvalidate.01" content="E2D2F4A90ED7FB194107E9FDE02AA5A4" /> <link rel="shortcut icon" href="/favicon.ico"> <link rel="canonical" href="https://www.alkermes.com" /> <link rel="preconnect" href="https://fonts.gstatic.com"> <link href="https://fonts.googleapis.com/css2?family=Nunito+Sans:ital,wght@0,300;0,400;0,600;0,700;1,300&display=swap" rel="stylesheet"> <link href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/css/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous"> <link href="/css/Site.min.css?v=20" rel="stylesheet" type="text/css" /> <link href="/kentico/bundles/pageComponents/styles?v=j7fMqFR0kPN_PnBqP8uKJ6bg7ISL3FkvOpDQ2YhIAvg1" rel="stylesheet"/> <link href="/kentico/bundles/formComponents/styles?v=Bi2-Kre-1_AROkaFpfUVwDnfBdm9W3gsby7j5NkNyHY1" rel="stylesheet"/> <!-- OptanonConsentNoticeStart --> <script src="https://cdn-ukwest.onetrust.com/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="14b20b82-5903-4048-911b-088fa18c4dc5"></script> <script type="text/javascript"> function OptanonWrapper() { } </script> <!-- OptanonConsentNoticeEnd --> <!-- Google Tag Manager --> <script> (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-WJGJPS');</script> <!-- End Google Tag Manager --> <script> var excludedSites = ["alkermes.com","alkermes.envisionpharma.com","alkermesmedinfo.com","app.smartsheet.com","aristada.com","aristadahcp.com","ch.tbe.taleo.net","chj.tbe.taleo.net","https://www.clinicaltrials.gov/","g.co","app.smartsheet.com","lybalvi.com","mailto:","maps.google.com","media.corporate-ir.net","phe.tbe.taleo.net","phx.corporate-ir.net","solutions.sciquest.com","vivitrol.com","vivitrolhcp.com","www.aaps.org","www.accessdata.fda.gov","www.acnp.org","www.candidatemanager.net","www.cmellc.com","www.controlledreleasesociety.org","www.cphi.com","www.icsexpo.com","www.interphex.com","www.smi-online.co.uk","www.visiongain.com","www1.recruitingcenter.net"]; </script> </head> <body> <!-- Google Tag Manager (noscript) --> <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WJGJPS" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript> <!-- End Google Tag Manager (noscript) --> <div class="page-wrap"> <header class="header"> <div class="menu"> <a href="/"> <img src="/images/logo.svg" alt="logo" /> </a> <nav role="navigation"> <ul> <li> <a href="/about-us" title="About Us">About Us</a> <ul> <li> <a href="/about-us#discoveralkermes" title="Discover Alkermes">Discover Alkermes</a> </li> <li> <a href="/about-us#our-values" title="Our Values">Our Values</a> </li> <li> <a href="/about-us/leadership" title="Leadership">Leadership</a> </li> <li> <a href="/about-us/diversity-inclusion-belonging" title="Diversity, Inclusion & Belonging">Diversity, Inclusion & Belonging</a> </li> <li> <a href="/about-us/awards-and-recognition" title="Awards and Recognition">Awards and Recognition</a> </li> <li> <a href="/about-us#partnering" title="Collaborations">Collaborations</a> </li> <li> <a href="/about-us#locations" title="Locations">Locations</a> </li> </ul> </li> <li> <a href="/medicines-and-focus" title="Medicines & Focus">Medicines & Focus</a> <ul> <li> <a href="/medicines-and-focus#our-focus" title="Our Focus">Our Focus</a> </li> <li> <a href="/medicines-and-focus#disease-areas" title="Disease Areas">Disease Areas</a> </li> <li> <a href="/medicines-and-focus#development" title="Innovative Medicines">Innovative Medicines</a> </li> <li> <a href="/medicines-and-focus#Third-Party-Products" title="Third-Party Medicines">Third-Party Medicines</a> </li> </ul> </li> <li> <a href="/research-and-development" title="Research & Development">Research & Development</a> <ul> <li> <a href="/research-and-development/pipeline" title="Pipeline">Pipeline</a> </li> <li> <a href="/research-and-development#technologies" title="Technologies & Capabilities">Technologies & Capabilities</a> </li> <li> <a href="/research-and-development#research-and-medical-grants" title="Research & Medical Grants">Research & Medical Grants</a> </li> <li> <a href="/research-and-development#clinical-trials" title="Clinical Trials">Clinical Trials</a> </li> <li> <a href="/research-and-development#early-access" title="Early Access">Early Access</a> </li> </ul> </li> <li> <a href="/responsibility" title="Responsibility">Responsibility</a> <ul> <li> <a href="/responsibility#corporate-responsibility" title="Corporate Responsibility">Corporate Responsibility</a> </li> <li> <a href="/responsibility/patient-engagement-advocacy" title="Patient Engagement & Advocacy">Patient Engagement & Advocacy</a> </li> <li> <a href="/responsibility/alkermes-inspiration-grants" title="Alkermes Inspiration Grants®">Alkermes Inspiration Grants<span lang="EN-IE" style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif">®</span></span></a> </li> <li> <a href="/responsibility#corporate-giving" title="Corporate Giving">Corporate Giving</a> </li> <li> <a href="/responsibility/latest-responsibility-report" title="Corporate Responsibility Reports">Corporate Responsibility Reports</a> </li> <li> <a href="/responsibility/public-policy" title="Public Policy">Public Policy</a> </li> </ul> </li> <li> <a href="https://investor.alkermes.com" title="Investors">Investors</a> <ul> <li> <a href="https://investor.alkermes.com/press-releases" title="Press Releases">Press Releases</a> </li> <li> <a href="https://investor.alkermes.com/investor-events-presentations" title="Investor Events / Presentations">Investor Events / Presentations</a> </li> <li> <a href="https://investor.alkermes.com/sec-filings" title="SEC Filings">SEC Filings</a> </li> <li> <a href="https://investor.alkermes.com/annual-reports" title="Annual Reports">Annual Reports</a> </li> <li> <a href="https://investor.alkermes.com/corporate-governance" title="Corporate Governance">Corporate Governance</a> </li> <li> <a href="https://investor.alkermes.com/stock-information" title="Stock Information">Stock Information</a> </li> <li> <a href="https://investor.alkermes.com/investor-resources" title="Investor Resources">Investor Resources</a> </li> <li> <a href="https://investor.alkermes.com/email-alerts" title="Email Alerts">Email Alerts</a> </li> </ul> </li> <li> <a href="/news-and-events" title="News & Events">News & Events</a> <ul> <li> <a href="https://investor.alkermes.com/press-releases" title="Press Releases">Press Releases</a> </li> <li> <a href="/news-and-events/our-stories" title="Our Stories">Our Stories</a> </li> <li> <a href="/news-and-events#media-resources" title="Media Resources">Media Resources</a> </li> <li> <a href="/news-and-events#statements-and-positions" title="Statements">Statements</a> </li> <li> <a href="/contact-us" title="Contact Us">Contact Us</a> </li> </ul> </li> <li> <a href="/careers" title="Careers">Careers</a> <ul> <li> <a href="/careers#working-here" title="Working Here">Working Here</a> </li> <li> <a href="/careers#our-culture" title="Our Culture">Our Culture</a> </li> <li> <a href="/careers#benefits" title="Benefits">Benefits</a> </li> <li> <a href="/careers#join-our-team" title="Join Our Team">Join Our Team</a> </li> </ul> </li> </ul> <div> <div class="search"> <img src="/images/icon-magnifier.png" alt="logo" /> </div> <div class="mobile-toggle"> <button class="navbar-toggler" aria-label="Toggle navigation"> <span class="navbar-toggler-icon"></span> </button> </div> </div> <div class="search-form"> <form action="/Search" method="get"> <input class="form-control" type="search" placeholder="Enter Search Terms" name="q"> <a class="search-close" role="button"></a> </form> </div> </nav> </div> </header> <div class=""> <div> <div class="row one-column-section page-hero"> <div class="col-md-12"> <div class="fr-view"> <div class="mb-md-5" style="height:45vw;"><img src="/getmedia/ed81a313-7840-4c1f-a1ca-9eb1c92f2654/Man-smiling-in-front-of-blue-curtain.jpg" class="d-none d-md-block fr-fil fr-dib" alt="portrait of smiling man stading in wooded area"><img src="/getmedia/c3a8f29c-c6a4-477a-b5bd-704417545e06/Man-smiling-in-front-of-blue-curtain-m.jpg" class="d-block d-md-none fr-fil fr-dib" alt="portrait of smiling man stading in wooded area"><img src="/getmedia/d5de477d-d1d3-462c-8415-b3cc9a083671/triangle_blue_top_right.png" data-strname="triangle_blue_top_right" data-strid="d5de477d-d1d3-462c-8415-b3cc9a083671" class="triangle fr-fic fr-fir fr-dii" alt="blue triangle graphic"><div><h1><br>Great Science<br>Deep Compassion<br>Real Impact</h1><h5>Leveraging our long-standing neuroscience<br>expertise to develop medicines that<br>make a difference.</h5><p><a class="white-rounded-border" href="/about-us">Discover Alkermes</a></p></div></div> </div> </div> </div> </div> <div class="row one-column-section"> <div class="fr-view col-md-12"> <div class="small-tile-light-blue-3-column"> <h3>Featured News</h3> <div> <img src="/getmedia/0381b0bb-1469-4cc8-acaa-2d765b487c0f/featured-investor-news.jpg?width=600&height=400&ext=.jpg" style="width: 100%;" class="fr-fic fr-dib" alt=""> <p> <strong><span style="color: #E30000;">November 25, 2024</span></strong> <br> <br>Alkermes to Participate in Upcoming Investor Conferences </p> <p><a class="blue-rounded-border" href="https://investor.alkermes.com/news-releases/news-release-details/alkermes-participate-upcoming-investor-conferences" rel="noopener noreferrer">Read more</a></p> </div> <div> <img src="/getmedia/db61a0bc-43f8-4e09-9672-91425bd9e055/featured-news-corporate-2_1.jpg?width=600&height=400&ext=.jpg" style="width: 100%;" class="fr-fic fr-dib" alt=""> <p> <strong><span style="color: #E30000;">November 11, 2024</span></strong> <br> <br>Alkermes to Participate in Two Upcoming Investor Conferences </p> <p><a class="blue-rounded-border" href="https://investor.alkermes.com/news-releases/news-release-details/alkermes-participate-two-upcoming-investor-conferences-3" rel="noopener noreferrer">Read more</a></p> </div> <div> <img src="/getmedia/f1d74df9-d3d6-45bc-ae8c-abb1cfecac32/featured-news-product.jpg?width=600&height=400&ext=.jpg" style="width: 100%;" class="fr-fic fr-dib" alt=""> <p> <strong><span style="color: #E30000;">November 07, 2024</span></strong> <br> <br>Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences </p> <p><a class="blue-rounded-border" href="https://investor.alkermes.com/news-releases/news-release-details/alkermes-highlights-presentations-across-neuroscience-portfolio" rel="noopener noreferrer">Read more</a></p> </div> <p><a class="dark-blue-fill" href="https://investor.alkermes.com/press-releases" rel="noopener noreferrer">See all press releases</a></p> </div> </div> </div> <div> <div class="row three-column-section section-news"> <div class="col-md-4 col-xs-12"> <div class="fr-view"> <p><img src="/getmedia/44c23d83-4df2-47dd-a6f9-a7472c106205/connor-scott-square.jpg" class="fr-fic fr-dib" alt="Smiling woman standing in hallway at Alkermes office."></p><div><h3>Responsible Growth</h3><p>Our most recent Corporate Responsibility Report, highlighting activities that took place in 2023, showcases Alkermes' commitment to acting as a responsible corporate citizen across a range of policies, programs and practices.</p><p style="text-align:right;"><a class="blue-rounded-border" href="/responsibility/latest-responsibility-report">View our latest report</a></p></div> </div> </div> <div class="col-md-4 col-xs-12"> <div class="fr-view"> <div><h3>Culture of Excellence</h3><p><br><br>Our employees' dedication to patients and our communities is foundational to our culture. Hear how our team members contribute to building an organization dedicated to creating real impact.</p><p style="text-align:right;"><a class="blue-rounded-border" href="https://www.alkermes.com/careers#culture-video">Watch the video</a></p></div><p><img src="/getmedia/4f39664e-15bf-4d26-bb79-75c60819b3bd/andrea-dacayanan.png" class="fr-fic fr-dib" alt="Man standing in lab coat with mask on in laboratory area at Alkermes."></p> </div> </div> <div class="col-md-4 col-xs-12"> <div class="fr-view"> <p><img src="/getmedia/c86a6c61-8069-454f-9453-fa30072ef601/nikki-henderson-2.png" class="fr-fic fr-dib" alt="Man sitting in front of green background at Alkermes office."></p><div><h3>Notable Recognition</h3><p>We are honored to be recognized as an employer of choice in the life sciences industry. Visit our Awards & Recognition page to see the latest accolades bestowed on Alkermes, based on the results of a third-party survey shared with our U.S.-based employees.</p><p style="text-align:right;"><a class="blue-rounded-border" href="/about-us/awards-and-recognition">Visit our Awards & Recognition page</a></p></div> </div> </div> </div> </div> <div class="pipeline-home"> <div class="col-xs-12 col-md-4" style="display: flex; flex-direction: column;margin-right:5vw;color: white;"> <div class="row one-column-section"> <div class="col-md-12"> <div class="fr-view"> <div><h3>R&D Pipeline </h3><p><br></p><h5>We apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We are currently focused on developing these investigational candidates.</h5><p style="margin-top:5vw;"><a class="white-rounded-border" href="/research-and-development/pipeline">Click to view our interactive pipeline</a></p></div> </div> </div> </div> </div> <div class="pipeline"> <div class="pb-3"> <div class="head d-none d-md-block"> <ul> <li>Discovery</li> <li>Preclinical</li> <li>Phase 1</li> <li>Phase 2</li> <li>Phase 3</li> </ul> </div> <div class="body"> <ul> <li class="molecule py-2"> <p class="m-0 pb-0">Olanzapine and samidorphan</p> <div class="toggle-overlay"></div> <ul> <li class="product"> <p class="mt-2">Schizophrenia and Bipolar I Disorder (Pediatric)</p> <div class="my-1 phase-100"> <div style="width:100%"></div> </div> <p class="d-md-none pb-3"> <span>Phase 3</span> </p> </li> </ul> <div class="extra"> <div class="d-flex flex-column"><strong>Overview</strong> <p>Olanzapine and samidorphan is a once-daily, oral atypical antipsychotic drug approved for adults in the U.S.</p></div> <div class="d-flex flex-column"><strong>Clinical Trials</strong> <p>Olanzapine and samidorphan is currently being evaluated for pediatric use in a phase 3 study. For more information about this study, please visit <strong><a href="https://www.enlightenyouthstudy.com" target="_blank">enlightenyouthstudy.com</a></strong> (U.S. audiences only) or <a href="https://www.clinicaltrials.gov/study/NCT05303064" target="_blank"><strong>clinicaltrials.gov/study/NCT05303064</strong></a>.</p></div> <div class="d-flex m-0"> </div> </div> </li> <li class="molecule py-2"> <p class="m-0 pb-0">ALKS 2680</p> <div class="toggle-overlay"></div> <ul> <li class="product"> <p class="mt-2">Narcolepsy Type 1</p> <div class="my-1 phase-80"> <div style="width:80%"></div> </div> <p class="d-md-none pb-3"> <span>Phase 2</span> </p> </li> <li class="product"> <p class="mt-2">Narcolepsy Type 2</p> <div class="my-1 phase-80"> <div style="width:80%"></div> </div> <p class="d-md-none pb-3"> <span>Phase 2</span> </p> </li> <li class="product"> <p class="mt-2">Idiopathic Hypersomnia</p> <div class="my-1 phase-60"> <div style="width:60%"></div> </div> <p class="d-md-none pb-3"> <span>Phase 1</span> </p> </li> </ul> <div class="extra"> <div class="d-flex flex-column"><strong>Overview</strong> <p>ALKS 2680 is an investigational, oral orexin 2 receptor agonist in development as a once-daily treatment for narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia.</p> </div> <div class="d-flex flex-column"><strong>Clinical Trials</strong> <p>ALKS 2680 is currently being evaluated in Vibrance-1, a phase 2 study in adults with narcolepsy type 1, and Vibrance-2, a phase 2 study in adults with narcolepsy type 2.<br /> <br /> For more information about these studies, please visit <strong><a href="https://vibrancestudies.com/?utm_source=alkermes&utm_medium=pipeline&utm_campaign=pipeline-2024" target="_blank">vibrancestudies.com</a></strong> (for U.S. audiences only) or the respective clinicaltrials.gov listings:</p> <ul> <li><strong>Vibrance-1: <a href="https://www.clinicaltrials.gov/study/NCT06358950" target="_blank">clinicaltrials.gov/study/NCT06358950</a></strong></li> <li><strong>Vibrance-2: <a href="https://www.clinicaltrials.gov/study/NCT06555783" target="_blank">clinicaltrials.gov/study/NCT06555783</a></strong></li> </ul> </div> <div class="d-flex m-0"> </div> </div> </li> <li class="molecule py-2"> <p class="m-0 pb-0">Orexin Agonists</p> <div class="toggle-overlay"></div> <ul> <li class="product"> <p class="mt-2">Neuroscience Indications</p> <div class="my-1 phase-39"> <div style="width:39%"></div> </div> <p class="d-md-none pb-3"> <span>Preclinical</span> </p> </li> <li class="product"> <p class="mt-2">Neuroscience Indications</p> <div class="my-1 phase-19"> <div style="width:19%"></div> </div> <p class="d-md-none pb-3"> <span>Discovery</span> </p> </li> </ul> <div class="extra"> <div class="d-flex flex-column"><strong>Overview</strong> <p>Additional orexin 2 receptor agonists are in discovery and preclinical research for the treatment of other neurological and psychiatric disorders.</p> </div> <div class="d-flex m-0"> </div> </div> </li> </ul> </div> <div class="foot"> <div class="fr-view"> <div style="display:flex;flex-direction:row;justify-content:space-between;flex-wrap:wrap;"><div style="width:100%;">These programs are investigating treatments or indications that have not received approval from a health authority. The information presented is not intended to convey conclusions of safety or efficacy. There is no guarantee that the outcome of these studies will result in approval by a health authority. </div><p><br></p><p><br></p><p><br></p><div style="width:100%;"><br></div><div style="width:100%;"><em>L</em><em>ast updated: October 2024</em></div></div> </div> <div> </div> </div> </div> </div> </div> <div> <div class="row one-column-section"> <div class="col-md-12"> <div class="fr-view"> <div class="centri"><div><h3>Careers</h3><h5 style="font-family:'Nunito Sans';"> We dare for progress every day. </h5><h5>We take pride in our unique and compassionate spirit.</h5><h5>Our shared mission to make a real impact for others drives our purpose.</h5><h5>With collaboration at our core, we believe that anything is possible.</h5><p style="margin-top:4vw;"><a class="white-rounded-border" href="/careers">Working at Alkermes</a></p></div></div> </div> </div> </div> <div class="row one-column-section"> <div class="col-md-12"> <div class="fr-view"> <div class="home-quote hide-quote-marks"><img src="/getmedia/ea548646-62cd-41d4-b656-06a640c525e1/greg-apostol2.jpg" style="width:100%;" class="fr-fic fr-dib" alt="Man with mask sitting in meeting talking to colleague at Alkermes."><img src="/getmedia/d5de477d-d1d3-462c-8415-b3cc9a083671/triangle_blue_top_right.png" data-strname="triangle_blue_top_right" data-strid="d5de477d-d1d3-462c-8415-b3cc9a083671" style="width: 25vw;position: absolute;bottom:0;left:0;transform: rotate(180deg);margin:0;" class="fr-fic fr-dib" alt="blue triangle graphic"><div><div class="blockquote col-6" style="color: rgb(239, 239, 239);"><h4><br>Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We are driven to help advance innovation in hopes of providing additional treatment options for people living with complex and often difficult-to-treat diseases.</h4></div></div></div> </div> </div> </div> </div> </div> </div> <div class="footer-wrapper"> <footer> <div class="footer-container"> <div class="row"> <div class="col-xs-3 logo"> <img src="/images/logo.svg" alt="logo" /> </div> <div class="col-xs-9 col-md-6"> <ul> <li> <a href="/contact-us">Contact Us</a> </li> <li> <a href="/terms-of-use">Terms of Use</a> </li> <li> <a href="/privacy">Privacy Policy</a> </li> <li> <a href="/sitemap">Sitemap</a> </li> </ul> </div> <div class="col-xs-3"> <div class="d-none d-md-block col-md-3"></div> <div class="col-xs-3"> <a href="https://www.youtube.com/channel/UC1CXRHrg3JzXO962jQctF7w" target="_blank" class="followus-link"> <img src="/images/youtube_logo.svg" alt="logo" /> </a> </div> <div class="col-xs-3"> <a href="https://twitter.com/alkermes" target="_blank" class="followus-link"> <img src="/images/tw-x_logo.svg" alt="logo" /> </a> </div> <div class="col-xs-3"> <a href="https://www.linkedin.com/company/alkermes" target="_blank" class="followus-link"> <img src="/images/li_logo.svg" alt="logo" /> </a> </div> </div> <div class="col-md-12 col-xs-9"> <div class="copyright"> © 2024 Alkermes. All rights reserved. </div> </div> </div> </div> </footer> </div> <div class="modal fade" id="leavingModal" tabindex="-1" aria-labelledby="exampleModalLabel" aria-hidden="true"> <div class="modal-dialog"> <div class="modal-content"> <div class="modal-header"> <p data-dismiss="modal">Close <button type="button" class="icon-modal-close" data-dismiss="modal" aria-label="Close"></button></p> </div> <div class="modal-body"> <p><strong>You are now leaving Alkermes.com.</strong></p> <p>Alkermes assumes no responsibility for information or statements on external websites.</p> </div> <div class="modal-footer"> <div style="width:100%;display:flex;justify-content:flex-end;padding-bottom: 2vw;"> <a href="#" class="agree green-rounded-border" data-dismiss="modal" aria-label="Agree" style="margin-right:2vw">Agree</a> <a href="#" class="back green-rounded-border" data-dismiss="modal" aria-label="Back">Go Back</a> </div> </div> </div> </div> </div> <script src="/kentico/bundles/jquery?v=QKUPSia3ECT_E95si24LagQNjDmMylaf2SScSZLbaYQ1"></script> <script src="/kentico/bundles/jquery-unobtrusive-ajax?v=yWiSJlfkRWGOtjh38MIfwsmv_b3zyMucdfkOPGDhEoA1"></script> <script src="/kentico/bundles/forms/scripts?v=-bjGh-FOT6yDTxgrHwJwJf92VzWLPBz3wNicLVM1-v01"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.0/dist/js/bootstrap.bundle.min.js" crossorigin="anonymous"></script> <script src="/js/site.js?v=12"></script> </body> </html>